Tacere Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Tacere Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034. (NCT02315638) | Tacere Therapeutics, Inc. | 2014-11-01 |
| Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C (NCT01899092) | Tacere Therapeutics, Inc. | 2014-01-01 |
Track Tacere Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.